[
    [
        {
            "time": "",
            "original_text": "仅一款在研新药接近上市！累亏4亿派格生物科创板IPO前景如何？ 亏损",
            "features": {
                "keywords": [
                    "新药",
                    "上市",
                    "累亏",
                    "派格生物",
                    "科创板",
                    "IPO"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "仅一款在研新药接近上市！累亏4亿派格生物科创板IPO前景如何？ 亏损",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【首发】铨融医药科技完成数千万B轮融资，凯乘资本继续担任独家财务顾问",
            "features": {
                "keywords": [
                    "首发",
                    "铨融医药",
                    "融资",
                    "B轮",
                    "凯乘资本",
                    "财务顾问"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【首发】铨融医药科技完成数千万B轮融资，凯乘资本继续担任独家财务顾问",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "创新迎来新拐点｜研发客临床年会首日精粹",
            "features": {
                "keywords": [
                    "创新",
                    "拐点",
                    "研发客",
                    "临床年会"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗研发"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "创新迎来新拐点｜研发客临床年会首日精粹",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]